Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

Leica Biosystems Acquires Kreatech

Photonics.com
Jul 2013
NEWCASTLE-UPON-TYNE, England, and AMSTERDAM, July 9, 2013 — Leica Biosystems has acquired privately held DNA fluorescent in situ hybridization (FISH) probes and target labeling reagents provider Kreatech Diagnostics for an undisclosed amount.

Kreatech will join Leica Biosystems’ Advanced Staining business unit based in the UK. The combined business will develop targeted biomarker menus for Leica’s instrument platforms.

The acquisition will enable Leica Biosystems “to better serve our cytogenetics and anatomic pathology customers,” said Dr. Matthias G. Weber, president of Leica Biosystems. “It will also enable us to actively support the future development of personalized medicine by research and drug development companies. By standardizing and supporting the interpretation of results with our Aperio ePathology imaging solutions, we will provide our customers with the ability to effectively and efficiently manage ever more complex diagnostic requirements.”

Leica Biosystems is a provider of ThermoBrite and Bond systems for labeling tissue specimens for diagnostic interpretation in cytogenetics and pathology laboratories.

For more information, visit: www.leicabiosystems.com or www.kreatech.com

Advanced Staining business unitAperio ePathologyBasic ScienceBiophotonicsbondBusinesscytogeneticsEnglandEuropeFISH probesimagingKreatech DiagnosticsLeica Biosystemspathologythe NetherlandsThermoBrite

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.